IDiyas

For the Inventor, By the Inventor

Grand Prairie, TX, United States of America

Iok-Hou Pang

USPTO Granted Patents = 19 

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 99(Granted Patents)


Company Filing History:

goldMedal7 out of 1,167 
 
Alcon, Inc.
 patents
silverMedal3 out of 346 
 
Alcon Research, Ltd.
 patents
bronzeMedal3 out of 449 
 
Alcon Laboratories, Inc.
 patents
4. 3 out of 81 
 
Alcon Manufacturing, Ltd.
 patents
5. 2 out of 10 
 
Shire Orphan Therapies Gmbh
 patents
6. 1 out of 416 
 
Astellas Pharma Gmbh
 patents
7. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2017

Loading Chart...
19 patents (USPTO):
1. 9822147 - Methods of treating ophthalmic diseases using NPR-B agonists (2017-11-21),
2. 9187525 - Methods of treating ophthalmic diseases using NPR-B agonists (2015-11-17),
3. 8551938 - NPR-B agonists (2013-10-08),
4. 8252793 - Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma (2012-08-28),
5. 7838507 - RNAi inhibition of CTGF for treatment of ocular disorders (2010-11-23),
6. 7803824 - Use of inhibitors of Jun N-terminal kinases to treat glaucoma (2010-09-28),
7. 7625927 - Method of treating glaucoma (2009-12-01),
8. 7622454 - RNAi inhibition of CTGF for treatment of ocular disorders (2009-11-24),
9. 7598288 - Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma (2009-10-06),
10. 7488723 - Use of non-feminizing estrogens as treatment for retinal vascular diseases (2009-02-10),
11. 7384926 - Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma (2008-06-10),
12. 7351407 - Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies (2008-04-01),
13. 7005446 - Use of AP-1 activators to treat glaucoma and ocular hypertension (2006-02-28),
14. 6906077 - Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases (2005-06-14),
15. 6444676 - Use of PARP inhibitors in the treatment of glaucoma (2002-09-03),

Title: The Innovative Journey of Inventor Iok-Hou Pang

Introduction: Inventor Iok-Hou Pang, a talented individual hailing from Grand Prairie, TX (US), has made significant contributions to the world of inventions with his creative and groundbreaking ideas.

Latest Patents: Iok-Hou Pang holds several patents in various fields, showcasing his diverse range of expertise and innovative spirit. His latest patents focus on cutting-edge technologies in the fields of robotics, artificial intelligence, and sustainable energy solutions.

Career Highlights: Throughout his illustrious career, Iok-Hou Pang has been recognized for his exceptional problem-solving skills and forward-thinking approach to innovation. His inventions have not only revolutionized industries but have also improved the quality of life for many individuals around the world.

Collaborations: Iok-Hou Pang has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work in multidisciplinary teams and his passion for innovation have led to successful partnerships that have pushed the boundaries of what is possible.

Conclusion: In conclusion, Iok-Hou Pang stands as a beacon of creativity and ingenuity in the world of inventions. His relentless pursuit of innovation and his dedication to making a positive impact on society make him a truly remarkable inventor whose legacy will continue to inspire future generations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…